Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The future of CLL treatment and more personalized approaches

Paula Cramer, MD, University of Cologne, Cologne, Germany, briefly discusses the importance of personalized treatment approaches in patients with chronic lymphocytic leukemia (CLL). Dr Cramer first highlights that several factors must be considered when making decisions about treatment personalization, and then goes on to share her thoughts on where the field is moving. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.